• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    CJ Cheiljedang Corporation's (KRX:097950) Shares May Have Run Too Fast Too Soon

    Simply Wall St·01/07/2026 23:15:59
    Listen to the news

    It's not a stretch to say that CJ Cheiljedang Corporation's (KRX:097950) price-to-sales (or "P/S") ratio of 0.1x right now seems quite "middle-of-the-road" for companies in the Food industry in Korea, where the median P/S ratio is around 0.3x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.

    AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

    View our latest analysis for CJ Cheiljedang

    ps-multiple-vs-industry
    KOSE:A097950 Price to Sales Ratio vs Industry January 7th 2026

    How Has CJ Cheiljedang Performed Recently?

    Recent times haven't been great for CJ Cheiljedang as its revenue has been rising slower than most other companies. Perhaps the market is expecting future revenue performance to lift, which has kept the P/S from declining. However, if this isn't the case, investors might get caught out paying too much for the stock.

    If you'd like to see what analysts are forecasting going forward, you should check out our free report on CJ Cheiljedang.

    Do Revenue Forecasts Match The P/S Ratio?

    In order to justify its P/S ratio, CJ Cheiljedang would need to produce growth that's similar to the industry.

    Taking a look back first, we see that there was hardly any revenue growth to speak of for the company over the past year. The longer-term trend has been no better as the company has no revenue growth to show for over the last three years either. So it seems apparent to us that the company has struggled to grow revenue meaningfully over that time.

    Shifting to the future, estimates from the analysts covering the company suggest revenue should grow by 2.0% over the next year. Meanwhile, the rest of the industry is forecast to expand by 13%, which is noticeably more attractive.

    With this information, we find it interesting that CJ Cheiljedang is trading at a fairly similar P/S compared to the industry. It seems most investors are ignoring the fairly limited growth expectations and are willing to pay up for exposure to the stock. Maintaining these prices will be difficult to achieve as this level of revenue growth is likely to weigh down the shares eventually.

    What We Can Learn From CJ Cheiljedang's P/S?

    Using the price-to-sales ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.

    Given that CJ Cheiljedang's revenue growth projections are relatively subdued in comparison to the wider industry, it comes as a surprise to see it trading at its current P/S ratio. When we see companies with a relatively weaker revenue outlook compared to the industry, we suspect the share price is at risk of declining, sending the moderate P/S lower. This places shareholders' investments at risk and potential investors in danger of paying an unnecessary premium.

    It is also worth noting that we have found 4 warning signs for CJ Cheiljedang (1 doesn't sit too well with us!) that you need to take into consideration.

    If you're unsure about the strength of CJ Cheiljedang's business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.